MRNA241018C58000
- 1.00
- -0.24-19.35%
Moderna Newsroom
Moderna Continues to Be the Most Shorted S&P 500 Healthcare Stock in September
Moderna Is Maintained at Hold by Jefferies
Unveiling 18 Analyst Insights On Moderna
Moderna Analyst Ratings
GSK Files Patent Infringement Case Against Moderna
glaxosmithkline sues Moderna for infringing its patent rights on the COVID-19 vaccine.
GlaxoSmithKline October 15th | GlaxoSmithKline filed a lawsuit against Moderna in the Federal Court of Delaware on Tuesday, alleging that Moderna's COVID-19 vaccine Spikevax infringed on its patents in mRNA technology. The company filed a similar lawsuit against Pfizer and biontech in the same court in April this year.
Express News | Glaxosmithkline Sues Moderna for U.S. Patent Infringement Over Mrna Technology in Covid-19 Vaccines - Court Filing
Jefferies Financial lowers Moderna's target price to $55.
October 15th, Jefferies Financial: Lowered Moderna's target price from $65 to $55. (GLENCORE)
Express News | Moderna : Jefferies Cuts Target Price to $55 From $65
Moderna (MRNA) Stock Sinks As Market Gains: Here's Why
Universal Health Services, DaVita, HCA Healthcare Among Top Healthcare Quant Picks Before Q3 Earnings
Cathie Wood's Ark Invest Dumps Over $9M In Moderna Stock — Even With Post-COVID Plans On The Table
Moderna Options Spot-On: On October 10th, 133.89K Contracts Were Traded, With 522.1K Open Interest
On October 10th ET, $Moderna(MRNA.US)$ had active options trading, with a total trading volume of 133.89K options for the day, of which put options accounted for 68.03% of the total transactions,
Wolfe's Tax Loss Selling Stocks Within Communications, Discretionary, Staples, Energy, Financials, Health Care
Personalized Treatment And Immunotherapy Are Pharma's Newest Weapons Against Cancer
Unusual Options Activity: CCL, MRNA and Others Attract Market Bets, CCL V/OI Ratio Reaches 77.9
EST Oct 10th Afternoon Delivery - In the last two hours of trading, 10 options with a high V/OI ratio were detected. With the market volatile, it's crucial to stay informed on the latest options
Moderna Stock Touches 52-week Low at $57.71 Amid Market Shifts
Healthcare Stocks Are Showing Life Beyond Lilly and GLP-1s -- Barrons.com
Redburn Atlantic Adjusts Moderna's Price Target to $73 From $102, Keeps Neutral Rating
Flagship Pioneering Announces Appointment of Paul Parker as Managing Partner, Leading Capital Solutions